Secondary Progressive Multiple Sclerosis Clinical Trials

ReadTheTrial indexes 1 studies for Secondary Progressive Multiple Sclerosis. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Secondary Progressive Multiple Sclerosis.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
100%

Trial Status Breakdown

Trials for Secondary Progressive Multiple Sclerosis

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis

NCT07299019 · RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Secondary Progressive Multiple Sclerosis?

There are 1 clinical trials listed for Secondary Progressive Multiple Sclerosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Secondary Progressive Multiple Sclerosis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Secondary Progressive Multiple Sclerosis trials in?

Current Secondary Progressive Multiple Sclerosis trials are distributed across: Phase 3 (1).

Find More Trials